1. Next indication for Pona with pre-clinical data (FLT-3?) 2. Status of several expected IST trials 3. Announcement that 12-month PACE data will be presented at ASH 2012 in December 4. Status of enrollment of EPIC trial 5. Status of Merck Rida trials (several have completed and new ones started without a peep) 6. Status of dose escalation on '113 - it has been 28 days since 240mg started.
And...wait for it....
7. Announcement of IND for 5th novel, internally discovered drug candidate!!
[Warning! Seems like we are going to need some more $$$.]
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.